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With its ability to form biofilms on 
the surfaces of indwelling medical 
devices, Staphylococcus epidermidis, a 
commensal bacterium of healthy human 
skin and mucosae, is one of the most 
common causes of nosocomial infec-
tions worldwide (1). Quantification of 
specific mRNA transcripts has proved 
to be very useful in identifying virulence 
determinants associated with S. epider-
midis biofilms, including resistance to 
antibiotics (2,3) and evasion from the host 
immune system response (4). However, 
mRNA transcript measurements can be 
fraught with bias, and high variability is 
frequently observed between experi-
ments, leading to inaccurate quantifi-
cation and misrepresentative results. 
Therefore, it is important to understand 
the origin of such variability in order to 
be able to mitigate it. Variability and bias 
in the quantification of gene expression 
has been attributed to biological factors, 
including (i) RNA degradation (5), (ii) the 
presence of inhibitors (6), and (iii ) the 
nature of the sample used (7), as well as 
non-biological factors such as (i) the use 
of different RNA extraction procedures 
(8), (ii ) complementary DNA (cDNA) 
synthesis, and (iii ) quantitative PCR 
(qPCR) kits (9,10). Here, we measured 
variability associated with all three key 
steps in gene expression quantification: 
RNA extraction, cDNA synthesis, and 
qPCR. Because of the heterogeneous 
nature of the biofilm samples (11), we 
also determined the variability inher-
ently associated with biofilm growth. 
Based on these results, we were able 
to devise a simple strategy to improve 
mRNA transcript quantification and to 
consequently enhance the accuracy of 
gene expression studies using biofilm 
samples.
Material and methods
Experimental workflow
To analyze the source of variability 
associated with quantitative gene 
expression analysis of biofilms, we 
devised an experimental setup that 
allowed us to determine the contribu-
tions of biofilm growth, RNA extraction, 
cDNA synthesis, and qPCR run to 
variability. The experimental workflow 
is illustrated in Figure 1A. In brief, to 
determine the overall variabil ity of 
the gene expression quantif ication 
process, RNA was isolated from 
four independent biofilms, and the 
expression of f ive dif ferent genes 
was then quantified. To exclude the 
contribution of the biological variability, 
four RNA extractions were performed 
from the same biofilm. To exclude the 
contribution of RNA extraction, one 
RNA sample was randomly selected 
from the previous four RNA extractions 
per formed and used to synthesize 
four dif ferent cDNA samples. Lastly, 
to rule out the contribution of reverse 
transcriptase reaction, one cDNA 
sample randomly selected from the 
four previously synthesized was used 
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Gene expression quantification can be a useful tool in studying the properties of bacterial biofilms. 
Unfortunately, techniques such as RNA extraction, cDNA synthesis, and quantitative PCR (qPCR) 
can introduce variability into mRNA transcript measurements, obscuring biologically relevant 
results. Here we sought to identify the steps that impair accurate gene expression quantification 
from Staphylococcus epidermidis biofilm samples. We devised an experimental setup that could be 
used to determine the contribution of each experimental step to the variability of mRNA transcript 
measurement. Among factors tested, biofilm growth contributed the most bias to gene expression 
quantification. Additional experiments demonstrated that pooling biofilms together reduced this 
variability, resulting in more accurate gene expression analysis results. We therefore recommend pooling 
in order to reduce the variability associated with gene expression quantification from biofilm samples.
Reports
METHOD SUMMARY
Here we identified biofilm growth as the major factor influencing the variability often observed in gene expression quantification 
assays. We showed that biofilm pooling resulted in more accurate, precise, and meaningful gene expression data analysis.
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to perform four independent qPCR 
runs.
For the biofilm pooling strategy 
(Figure 1B), 4 independent pools of 10 
or 20 biofilms were thoroughly mixed 
by gentle vortexing, and then each pool 
was divided in 2 equivalent samples. 
Each of these samples was used for 
RNA extraction, cDNA synthesis, and 
qPCR. Nevertheless, for the determi-
nation of the coefficient of variation 
(CV), we only used the values from four 
independent pools. The other samples 
were used as internal controls for the 
RNA extraction experiment, being 
the experiments validated when the 
variability between pairs was similar. 
It is important to stress that the same 
reagent brands, the same operator, 
and the same equipment were strictly 
maintained throughout the experi-
ments because these factors are also 
known to introduce variability in gene 
expression quantification assays (12).
Bacterial and growth conditions
For quantif ication of the variabil ity 
associated with gene expression 
assays, the S. epidermidis strains 
RP62A (ATCC 35984) (13), clinical 
isolate 9142 (14), and commensal 
isolate JI6 (15) were used. Other strains 
included in the study are listed in Table 1. 
A single colony of each strain was 
inoculated into 1 mL of tryptic soy 
broth ( TSB) (L iof i lchem, Roseto 
degli Abruzzi, Italy) and incubated 
overnight at 37°C with shaking at 
120 rpm. Thereaf ter, a bacter ia l 
suspension with an optical density at a 
wavelength of 640 nm (A640) of 0.250 ± 
0.05 was prepared in fresh TSB, and 
a 15 µL aliquot of this suspension 
was inoculated into 1 mL TSB supple-
mented with 1% (v/v) glucose (Fisher 
 Scientif ic, Waltham, MA) to induce 
biof i lm formation in 24-well plates 
(Orange Scientif ic, Braine-l’Alleud, 
Belgium). The plates were incubated 
for 24 h at 37°C with shaking at 
120 rpm. Before any analysis, spent 
medium was removed, and biofilms 
were washed twice and suspended 
in 2 mL 0.9% NaCl (AnalaR Normapur, 
Radnor, PA).
S. epidermidis isolates characterization 
S. epidermidis isolates used for this 
study were selected from a collection 
of clinical and commensal isolates 
that were characterized in terms of 
their ability to form biofilms and for 
the presence of the genes of interest. 
In brief, biofilm formation capability 
was determined by A640 as described 
elsewhere (16). The presence of the 
genes of interest was determined by 
PCR using DreamTaq PCR Master Mix 
Figure 1. Experimental workflow for assessing sources of gene expression variation. (A) Workflow that was followed to determine the coefficient of varia-
tion associated with RNA extraction, cDNA synthesis, quantitative PCR (qPCR) run, and biofilm growth. (B) Workflow that was followed to validate the use 
of biofilm pools to decrease biofilm growth-associated variability. 
Table 1. Biofilm formation ability and presence of the genes of interest in different clinical and commensal 
Staphylococcus epidermidis isolates.
Strain Genes of interest Biofilm formation 
(OD640nm)
Collection
RP62A aap, lrgB, fmtC, icaA, pgi 1.269 ± 0.017 Intravascular catheter-associated sepsis (13)
9142 aap, lrgB, fmtC, icaA, pgi 0.823 ± 0.353 Blood clinical isolate (14)
1457 aap, lrgB, fmtC, icaA, pgi 0.810 ± 0.243 Central venous catheter-associated infection (14)
M129 aap, lrgB, fmtC, icaA 0.410 ± 0.117 Dialysis-associated peritonitis (15)
IE186 aap, lrgB, fmtC, icaA 0.729 ± 0.218 Infective endocarditis (15)
FJ6 aap, lrgB, fmtC, icaA, pgi 0.384 ± 0.203 Skin of healthy volunteers (15)
JI6 aap, lrgB, fmtC, icaA, pgi 0.573 ± 0.119 Skin of healthy volunteers (15)
LE7 lrgB, fmtC, icaA, pgi 0.853 ± 0.335 Skin of healthy volunteers (15)
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(Thermo Scientif ic, Waltham, MA). 
The oligonucleotide sequences of the 
primers used in this study are listed in 
Table 2, and the thermal cycler condi-
tions were the same used for qPCR, 
which are described below.
RNA extraction
RNA extraction was performed as 
optimized previously (10). In brief, this 
protocol uses both chemical (phenol; 
AppliChem, Darmstadt, Germany) 
and mechanical (glass beads; Sigma-
Aldrich, St. Louis, MO ) lysis together 
with column systems for RNA isolation 
(E.Z.N.A Total RNA kit I, Omega 
Bio-Tek, Norcross, GA). Genomic DNA 
was digested with DNase I (Thermo 
Scientific) following the manufacturer’s 
instructions, and RNA concentration 
and purity were determined using a 
NanoDrop 1000 spectrophotometer 
(Thermo Scientific). The absorbance 
ratios A260/A280 and A260/A230 were 
used as indicators, respectively, of 
protein contamination and polysac-
charide, phenol, or chaotropic salt 
contamination (17). To determine RNA 
integrity, 23S and 16S rRNA banding 
patterns were evaluated in nondena-
turing gel electrophoresis. Electropho-
resis was carried out at 80 V for 60 
min in a 1.5% agarose gel. The gel was 
stained with Midori Green Advanced 
DNA stain (Nippon Genetics Europe, 
Dueren, Germany) and visualized using 
a ChemiDoc XRS (Bio-Rad, Hercules, 
CA). Because RNA integrity signifi-
cantly influences the quantification of 
gene expression (5,6), only samples 
Table 2. Oligonucleotide sequences of the primers used for PCR characterization and gene expression quan-
tification by qPCR.
Target gene Primer sequence  
(5´ to 3´)
Melting temperature 
(°C)
Amplicon 
(bp)
Priming efficiency 
(%)
16S rRNA FW
RV
GGGCTACACACGTGCTACAA
GTACAAGACCCGGGAACGTA
59.79
59.85
176 93
aap FW
RV
GCACCAGCTGTTGTTGTACC
GCATGCCTGCTGATAGTTCA
59.22
59.98
190 95
icaA FW
RV
TGCACTCAATGAGGGAATCA
TAACTGCGCCTAATTTTGGATT
60.20
59.99
134 90
lrgB FW
RV
ATATCGCAAGCGCGAAGTAT
ATTGCTGTCGTTGCAGCTT
59.87
59.61
165 90
pgi FW
RV
TACTACGACAGAACCAGCAG
CATCAGGTACAACAAACGTC
54.05
53.95
170 85
fmtC FW
RV
CGCCCTCATCATAGCATTG
CCAATTGGATCACCCAAAAC
60.19
60.03
182 97
Figure 2. Coefficient of variation (CV) associated with biofilm-growth and each of the three key steps in 
gene expression quantification assays. Single biofilms of Staphylococcus epidermidis strain RP62A were 
used for these experiments. Four independent experiments were performed. qPCR: quantitative PCR.
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presenting comparable RNA quality, as 
determined by the presence of sharp 
bands and a 2:1 intensity ratio between 
23S and 16S rRNA, were used in this 
study.
Complementary DNA synthesis
Complementary DNA (cDNA) was 
synthesized as described elsewhere 
(10). In brief, 0.5 µg of total RNA was 
converted into cDNA in the presence of 
the enzyme RevertAid H minus reverse 
transcriptase (RT) (Thermo Scientific) 
in an MJ Mini Gradient Thermal cycler 
(Bio-Rad). Random primers (NZYTech, 
Lisbon, Portugal) were used as the 
priming strategy. To determine genomic 
DNA carry-over and contamination of 
the reagents used, control reactions 
lacking RT (no-RT control) and the 
template were prepared.
Quantitative PCR run
For mRNA quantif ication, a previ-
ously optimized qPCR reaction was 
performed (10). The primers (Metabion, 
Steinkirchen, Germany) used were 
designed using Primer3 sof tware 
(18) (Table 2). The experiment was 
performed in a CFX96 Thermal cycler 
(Bio-Rad) with the following cycling 
parameters: 10 min at 94°C followed 
by 40 repeats of 5 s at 94°C, 10 s at 
58°C, and finally 15 s at 72°C using 
iQ SYBR Green supermix (Bio-Rad). 
Reaction efficiency was determined 
by the dilution method (19) and using a 
temperature gradient from 50° to 65°C. 
At 58°C, all set of primers used had 
the best and most similar efficiencies. 
RNA samples were considered free 
from significant genomic DNA contam-
ination if the quantification cycle (Cq) 
difference between the specific signal 
and the respective no-RT control was 
greater than 10. Neither unanticipated 
products nor primer dimers were 
detectable by melting curve analysis. 
The quantif ication of the specif ic 
transcripts for each gene under study 
was determined using the delta Cq 
method (E∆Cq), a variation of the Livak 
method (20), where ∆Cq = Cq (reference 
gene) - Cq (target gene) and E is the 
experimentally determined reaction 
efficiency.
Statistical analysis
The CV was determined as a measure 
of var iabi l i ty. Mean and standard 
deviation were determined using 
Microsoft Office Excel 2007.
Results and discussion
Gene expression quantification using 
qPCR requires the col lection of 
biological material; RNA extraction; 
and cDNA synthesis, amplif ication, 
and quantification. Each of these steps 
can introduce variability in the quantifi-
cation process, resulting in inaccurate 
gene express ion quant i f i cat ion 
(7–10,21). We conceived a simple 
experimental design (Figure 1A) that 
allowed us to determine the relative 
contributions of RNA extraction, cDNA 
synthesis, and qPCR, as well as the 
impact of biof i lm growth, on gene 
expression quantification variability. 
Because gene-associated particu-
larities can impact mRNA transcript 
measurements in dif ferent ways, we 
analyzed the expression of five genes 
with distinct functions, plus the 16S 
RNA control. The genes included 
( i ) aap (22), which is involved in 
protein-associated biofilm formation 
and accumulation; ( i i ) icaA, which 
is involved in both polysaccharide-
mediated biofilm accumulation (23) and 
immune evasion (15); ( i i i ) pgi, which 
plays a role in glucose metabolism (24); 
(iv) fmtC (also known as mprF ), which 
is involved in L-lysine modif ication 
of phosphatidylglycerol and immune 
evasion (25); and (v ) l rgB, which 
has been linked with programmed 
cell death (26). We quantif ied the 
expression of these selected genes in 
four independently grown biofilms and 
calculated the experimental variability. 
As depicted in Figure 2, the overall CV 
of our experimental setup was 61% ± 
26%, with the highest disparity in pgi 
gene (87%) expression and the lowest 
in lrgB gene (27%) expression. 
To exc lude the in f luence of 
biological variability and to assess 
the variability introduced by the RNA 
isolation procedure, we performed 
four parallel RNA extractions from 
the same biofilm samples. Interest-
ingly, our experimental setup revealed 
that RNA extraction and subsequent 
steps accounted for a CV of only 23% 
± 10% (Figure 2). As before, gene-to-
gene variation was observed, with the 
highest variation associated with the 
pgi gene (37%) and the lowest with the 
icaA gene (15%). Next, we examined 
intr insic variabil ity associated wih 
cDNA synthesis process by performing 
four different synthesis reactions from 
the same randomly selected RNA 
sample. The overall CV observed was 
Figure 3. Coefficient of variation (CV) of gene expression quantification 
assays using a single biofilm sample or pools of 10 or 20 biofilms. Staphy-
lococcus epidermidis strain RP62A biofilms were used for these experi-
ments. Four independent experiments were performed.
Figure 4. Coefficient of variation (CV) of gene expression quantification 
assays using a single biofilm or a pool of 10 biofilms. Staphylococcus epi-
dermidis strain 9142 and JI6 biofilms were used for these experiments. 
Four independent experiments were performed.
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24% ± 5%, and again, the highest 
variation was associated with the pgi 
gene (30%) and the lowest with the 
icaA gene (17%) (Figure 2). 
To rule out variabil ity inherently 
associated with cDNA synthesis and 
determine the variability introduced 
during qPCR, we randomly selected 
one of the previously synthesized 
cDNA and performed four independent 
qPCR amplifications. The CV deter-
mined for this experiment was 15% ± 
4%, with the pgi gene again showing 
the greatest variation (22%) and the 
lrgB gene having the least variation 
(11%) (Figure 2). We repeated the 
experiment with dif ferent randomly 
selected RNAs and cDNAs obtaining 
similar results (data not shown). 
It is important to emphasize that the 
variation introduced by each step is 
strictly dependent on the kit used, as 
different commercially available kits will 
exhibit dif ferences in reproducibility 
(7,9) and consequently, the CVs deter-
mined here are merely representative. 
Never theless, our f indings clearly 
indicate that among the variables 
studied, biof i lm growth made the 
greatest contribution to the variability 
detected in gene expression quantifi-
cation. Given this finding, we wanted 
to devise a strategy to decrease such 
variability.
Considering biofilms are very hetero-
geneous samples (11), we attempted 
to pool several biofilms (Figure 1B) 
to determine whether such a pooling 
strategy could decrease the variability. 
We pooled together either 10 or 20 
biofilms that were grown in 24-well 
plates and then per formed 2 RNA 
extractions from each pool. To assess 
the gene expression variability in the 
biofilm pools, we selected the gene 
with the highest variation detected 
in our initial experiments (pgi ) and a 
gene with lower variably (aap), being 
the last directly involved in biofilm 
formation. As can be seen in Figure 3, 
biof i lm pool ing reduced the high 
variability associated with S. epider-
midis RP62A biof i lm growth (an 
average of 3.5-fold for the pool of 10 
biofilms and 3.8-fold for the pool of 
20 biofilms). Interestingly, the values 
obtained from the pool of 20 biofilms 
were as low as the variability introduced 
by qPCR amplif ication, suggesting 
that this pooling strategy was able 
to eliminate the variability introduced 
by the biofilm itself. When 10 biofilms 
were pooled, the variability detected 
was slightly higher, but nevertheless, 
there was a drastic reduction in the 
gene expression variability observed 
under our experimental conditions.
To verify that these findings were 
strain independent, the experiment 
was repeated using different S. epider-
midis isolates. For these experiments, 
we characterized a collection of clinical 
and commensal isolates for the ability 
to form biof i lm and the presence 
of the genes of interest (Table 1), 
selecting the clinical isolate 9142 and 
the commensal isolate JI6 for the 
validation of our strategy. Importantly, 
the same trend was observed for both 
clinical (average of 2.6-fold reduction) 
and commensal isolates (average of 
2.1-fold reduction), further suggesting 
this biofilm pooling strategy is gene 
and strain independent (Figure 4).
In conclusion, our data show that 
biofilm growth, among the studied 
variables, is the major factor inf lu-
encing the variability of biofilm gene 
expression quanti f ication assays. 
Application of a corrective strategy, 
pooling multiple biof i lms, led to a 
meaningful decrease in variance and 
more accurate and feasible gene 
expression analysis. Although our 
experimental design was validated 
for qPCR gene quantif ication, this 
strategy should also prove valid for 
biofilm transcriptomic analysis using 
RNA sequencing and microarrays.
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